Volonaki, Eleni <br/><br/>
Adalimumab as a second-line biological therapy in children with refractory ulcerative colitis.  [electronic resource] 

 -  European journal of gastroenterology & hepatology  Dec 2015 
 - 1425-8 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1473-5687 
<br/><br/><label>Standard No.: </label>10.1097/MEG.0000000000000470  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab--administration & dosage<br/>Adolescent<br/>Anti-Inflammatory Agents, Non-Steroidal--administration & dosage<br/>Child<br/>Colectomy<br/>Colitis, Ulcerative--drug therapy<br/>Drug Administration Schedule<br/>Drug Evaluation--methods<br/>Drug Therapy, Combination<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Infliximab--therapeutic use<br/>Male<br/>Remission Induction<br/>Retrospective Studies